← All trials
NCT00281047
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2006
- Primary completion
- —
- Completion date
- May 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 138
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Hamamatsu UniversityLead sponsor
- Oita UniversityStudy chair
- Oita UniversityStudy director
- Hamamatsu UniversityStudy director
- Oita UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.